These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10652236)

  • 21. Extracellular glutamate alters mature osteoclast and osteoblast functions.
    Seidlitz EP; Sharma MK; Singh G
    Can J Physiol Pharmacol; 2010 Sep; 88(9):929-36. PubMed ID: 20921979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different calcium sensitivity in osteoclasts on glass and on bone and maintenance of cytoskeletal structures on bone in the presence of high extracellular calcium.
    Lakkakorpi PT; Lehenkari PP; Rautiala TJ; Väänänen HK
    J Cell Physiol; 1996 Sep; 168(3):668-77. PubMed ID: 8816921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased MK-801 binding in discrete hippocampal regions of prion-infected mice.
    Diez M; DeArmond SJ; Groth D; Prusiner SB; Hökfelt T
    Neurobiol Dis; 2001 Aug; 8(4):692-9. PubMed ID: 11493033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
    Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA
    Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
    Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
    J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts.
    Holliday LS; Welgus HG; Hanna J; Lee BS; Lu M; Jeffrey JJ; Gluck SL
    Calcif Tissue Int; 2003 Mar; 72(3):206-14. PubMed ID: 12522662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice.
    Lee JK; Choi SS; Lee HK; Han KJ; Han EJ; Suh HW
    Mol Cells; 2002 Dec; 14(3):339-47. PubMed ID: 12521295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks.
    Okumura S; Mizoguchi T; Sato N; Yamaki M; Kobayashi Y; Yamauchi H; Ozawa H; Udagawa N; Takahashi N
    Bone; 2006 Oct; 39(4):684-93. PubMed ID: 16774853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.
    Gu Y; Genever PG; Skerry TM; Publicover SJ
    Calcif Tissue Int; 2002 Mar; 70(3):194-203. PubMed ID: 11907717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
    Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organization of osteoclast microfilaments during the attachment to bone surface in vitro.
    Lakkakorpi P; Tuukkanen J; Hentunen T; Järvelin K; Väänänen K
    J Bone Miner Res; 1989 Dec; 4(6):817-25. PubMed ID: 2692403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Podosome and sealing zone: specificity of the osteoclast model.
    Jurdic P; Saltel F; Chabadel A; Destaing O
    Eur J Cell Biol; 2006 Apr; 85(3-4):195-202. PubMed ID: 16546562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of osteoclast mediated bone resorption.
    Väänänen HK; Hentunen T; Lakkakorpi P; Parvinen EK; Sundqvist K; Tuukkanen J
    Ann Chir Gynaecol; 1988; 77(5-6):193-6. PubMed ID: 3076045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
    Hall TJ; Schaeublin M; Chambers TJ
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1245-53. PubMed ID: 8216256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of bone resorption and osteoclast clear zone formation by low pH: a time-course study.
    Murrills RJ; Stein LS; Dempster DW
    J Cell Physiol; 1993 Mar; 154(3):511-8. PubMed ID: 8436600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
    Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.